Results 31 to 40 of about 33,479 (238)
Rationale, definition, and history of transarterial chemoembolization
, 2023 Transarterial chemoembolization (TACE) is a minimally invasive technique used for the treatment of liver’s malignancies, mostly hepatocellular carcinoma (HCC).
Feliciangeli, Valeria +4 more
core +1 more source
Annals of Medicine, 2022 Purpose Skeletal muscle index (SMI) is a promising predictor of clinical outcomes in patients with malignant diseases. As a simpler surrogate of sarcopenia-psoas muscle index (PMI), its predict value for overall survival (OS) after transarterial ...
Jin-Xing Zhang +6 more
doaj +1 more source
Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation [PDF]
, 2012 Purpose: To evaluate the efficiency of a multimodality approach consisting of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) as bridging therapy for patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver
Rentsch, M. +33 more
core +1 more source
Chemotherapy and chemoembolization of patients with oncopathology as a risk factor for the development of myocardial dysfunction [PDF]
, 2023 Considering the aging of the population, the combination of cardiovascular diseases with oncopathology is gaining more relevance. Liver cancer occupies the 6th place in the structure of the incidence of neoplasms and the 3rd place in mortality from all ...
Aruzhan Abdilda +4 more
core +2 more sources
International Journal of Gastrointestinal Intervention, 2020 Super-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral ...
Toshiyuki Irie +2 more
doaj +1 more source
Radiology and Oncology, 2016 The purpose of this retrospective study was to evaluate treatment response, adverse events and survival rates of patients with intermediate stage HCC treated with superselective doxorubicin-loaded DC Bead transarterial chemoembolization (DEBDOX) under ...
Popovic Peter +3 more
doaj +1 more source
Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives [PDF]
, 2011 Hepatocellular carcinoma (HCC) is among the most common cancer diseases worldwide. Arterial hypervascularisation is an essential step for HCC tumorigenesis and can be targeted by transarterial chemoembolization (TACE).
Trojan, Jörg, Welker, Martin-Walter
core +1 more source
Drug Delivery, 2021 Transarterial chemoembolization is a standard treatment for intermediate-stage hepatocellular carcinoma (HCC). This study evaluated the anti-tumor effect of the semi-interpenetrating network (IPN) hydrogel as a novel embolic material for trans-portal ...
Xinxiang Yang +11 more
doaj +1 more source
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]
, 2012 The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria +6 more
core +1 more source
대한영상의학회지, 2018 Bone metastasis is the third most common extrahepatic metastasis from hepatocellular carcinoma (HCC), following lung and lymph node metastasis. Although transcatheter arterial chemoembolization (TACE) is widely used for the treatment for unresectable HCC
Hye Ji Ryu, Sung Nam Moon, Nam Kyu Chang
doaj +1 more source